Overview | Medtronic

Medtronic Investors

Creating
Long-term
Shareholder
Value

Our leading technologies and services create value on a global scale.

Latest Investor Information

February 19, 2019

Q3 2019 Medtronic plc Earnings Conference Call

January 17, 2019

Medtronic Pain Therapies Investor Briefing from NANS

January 07, 2019

37th Annual J.P. Morgan Healthcare Conference

Latest Press Releases

February 17, 2019	Medtronic Announces Preliminary PRODIGY Results: a Global Study to Identify Patients at High Risk for Opioid-Induced Respiratory Compromise
February 15, 2019	Medtronic Statement Regarding Revised IN.PACT Post Market Study Data
February 14, 2019	Medtronic and Medical University of South Carolina Partner to Improve Patient Outcomes
February 08, 2019	Medtronic to Announce Financial Results for Its Third Quarter of Fiscal Year 2019

Medtronic ESG & Corporate Citizenship Highlights

Medtronic Marks a Decade on the North American Dow Jones Sustainability Index (DJSI)

Opportunities to Obtain Irish Dividend Withholding Tax (DWT) Exemption

Important Information on the Irish Dividend Withholding Tax.

QUARTERLY

RESULTS

Medtronic Q2 revenue results and financial tables.

INVESTOR

FUNDAMENTALS

View snapshots of revenue and earnings, trading statistics, balance sheet, income statement, cash flow and ratios.

INSTITUTIONAL
INVESTOR AND
ANALYST MEETING
2018

Promising therapy and product innovation detailed by company leaders
READ HIGHLIGHTS

ACCESS WEBCAST REPLAY

img.alt

Sustainability Index Endorsements

Read more about our Sustainability efforts.

img.alt

Medtronic Spotlight

Medtronic CEO, Omar Ishrak sits down with CNBC’s Jim Cramer, to talk about the company’s analyst day and it’s fastest growing products.

img.alt

History of Medtronic

A video history of the company.

Investor Contacts

Stock Transfer Agent

EQ Shareowner Services
+1 888-648-8154

Medtronic Investor Relations Department

investor.relations@medtronic.com

+1 763-505-2692

Ryan Weispfenning

Vice President, Investor Relations